HER2-POSITIVE SOLID TUMOR
Clinical trials for HER2-POSITIVE SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE SOLID TUMOR trials appear
Sign up with your email to follow new studies for HER2-POSITIVE SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients receive novel Two-Target cancer drug in global trial
Disease control Recruiting nowThis is the first time researchers are testing a new drug called YH32367 in people. The study aims to find a safe and effective dose for patients with advanced HER2-positive cancers that have spread or cannot be removed by surgery. The drug is designed to attack cancer cells in t…
Matched conditions: HER2-POSITIVE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test 'Click' to clear cancer imaging tracers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging technique for cancers that have a protein called HER2, like some breast and stomach cancers. Researchers are using a special radioactive tracer attached to an antibody (trastuzumab) that targets HER2. After the tracer reaches the tu…
Matched conditions: HER2-POSITIVE SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC